UBS Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-445,197
| Closed | -$15.6M | – | 9139 |
|
|
2024
Q1 | $15.6M | Buy |
445,197
+364,412
| +451% | +$12.7M | ﹤0.01% | 1339 |
|
|
2023
Q4 | $3.07M | Buy |
80,785
+42,782
| +113% | +$1.63M | ﹤0.01% | 2454 |
|
|
2023
Q3 | $697K | Buy |
38,003
+36,192
| +1,998% | +$664K | ﹤0.01% | 3370 |
|
|
2023
Q2 | $47K | Sell |
1,811
-47,171
| -96% | -$1.22M | ﹤0.01% | 5446 |
|
|
2023
Q1 | $924K | Sell |
48,982
-40,265
| -45% | -$760K | ﹤0.01% | 3243 |
|
|
2022
Q4 | $2.2M | Buy |
89,247
+71,452
| +402% | +$1.76M | ﹤0.01% | 2498 |
|
|
2022
Q3 | $319K | Buy |
+17,795
| New | +$319K | ﹤0.01% | 3730 |
|
|
2022
Q2 | – | Sell |
-32,343
| Closed | -$721K | – | 10556 |
|
|
2022
Q1 | $721K | Sell |
32,343
-4,615
| -12% | -$103K | ﹤0.01% | 3512 |
|
|
2021
Q4 | $1.61M | Buy |
+36,958
| New | +$1.61M | ﹤0.01% | 3044 |
|
|
2021
Q2 | – | Sell |
-2,522
| Closed | -$51K | – | 9168 |
|
|
2021
Q1 | $51K | Buy |
2,522
+596
| +31% | +$12.1K | ﹤0.01% | 5537 |
|
|
2020
Q4 | $64K | Buy |
1,926
+839
| +77% | +$27.9K | ﹤0.01% | 4986 |
|
|
2020
Q3 | $20K | Buy |
+1,087
| New | +$20K | ﹤0.01% | 5464 |
|